Compass Wealth Management LLC Has $4.50 Million Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Compass Wealth Management LLC decreased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 14.1% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 13,007 shares of the company’s stock after selling 2,139 shares during the quarter. Compass Wealth Management LLC’s holdings in HCA Healthcare were worth $4,495,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the stock. Farther Finance Advisors LLC increased its holdings in shares of HCA Healthcare by 26.9% during the 1st quarter. Farther Finance Advisors LLC now owns 1,141 shares of the company’s stock worth $395,000 after acquiring an additional 242 shares during the last quarter. Oppenheimer Asset Management Inc. boosted its stake in HCA Healthcare by 2.5% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 4,314 shares of the company’s stock valued at $1,491,000 after purchasing an additional 105 shares during the period. GAMMA Investing LLC lifted its position in shares of HCA Healthcare by 17.6% during the 1st quarter. GAMMA Investing LLC now owns 4,931 shares of the company’s stock valued at $1,704,000 after acquiring an additional 737 shares during the period. Brighton Jones LLC bought a new stake in shares of HCA Healthcare during the 4th quarter valued at $1,021,000. Finally, OLD National Bancorp IN raised its holdings in shares of HCA Healthcare by 5.2% during the 1st quarter. OLD National Bancorp IN now owns 1,049 shares of the company’s stock worth $362,000 after buying an additional 52 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA opened at $372.84 on Friday. The company has a current ratio of 1.19, a quick ratio of 1.06 and a debt-to-equity ratio of 69.07. The firm has a market cap of $89.69 billion, a PE ratio of 16.58, a price-to-earnings-growth ratio of 1.30 and a beta of 1.47. The company’s 50 day simple moving average is $371.55 and its 200-day simple moving average is $339.38. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, April 25th. The company reported $6.45 EPS for the quarter, topping the consensus estimate of $5.75 by $0.70. The company had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. The business’s revenue was up 5.7% on a year-over-year basis. During the same period in the previous year, the firm earned $5.36 EPS. As a group, equities analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, June 30th. Shareholders of record on Monday, June 16th were issued a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.77%. The ex-dividend date of this dividend was Monday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is 12.81%.

Analyst Ratings Changes

Several equities analysts have commented on HCA shares. Robert W. Baird reiterated a “neutral” rating and issued a $336.00 target price (down from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. Wall Street Zen upgraded HCA Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday. Royal Bank Of Canada restated an “outperform” rating and set a $404.00 price objective (up from $376.00) on shares of HCA Healthcare in a research report on Monday, June 23rd. Stephens upgraded shares of HCA Healthcare to a “strong-buy” rating in a report on Monday, June 2nd. Finally, Barclays set a $416.00 price objective on shares of HCA Healthcare and gave the stock an “overweight” rating in a research note on Monday, June 2nd. Seven research analysts have rated the stock with a hold rating, eleven have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $395.71.

Insider Activity

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the company’s stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the transaction, the chief operating officer owned 12,646 shares in the company, valued at $4,670,420.72. This represents a 55.38% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 1.30% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.